Asthma evaluation and management

Emergency Medicine Clinics of North America

Volumn 21, Issue 2, 2003, Pages 315-330

  Adams, Brian K ^a   Cydulka, Rita K ^a  

^a METROHEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIASTHMATIC AGENT; ATROPINE; BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; DEXAMETHASONE; GLYCOPYRRONIUM BROMIDE; HALOTHANE; HELIOX; INHALATION ANESTHETIC AGENT; IPRATROPIUM BROMIDE; KETAMINE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MAGNESIUM SULFATE; METHYLPREDNISOLONE; METHYLXANTHINE; MONTELUKAST; NEDOCROMIL; PRANLUKAST; PREDNISONE; SALBUTAMOL; TERBUTALINE; THEOPHYLLINE; UNINDEXED DRUG; ZAFIRLUKAST; ZILEUTON;

ADOLESCENT; ADRENAL INSUFFICIENCY; ADULT; AGED; ANESTHESIA INDUCTION; ARTIFICIAL VENTILATION; ASEPTIC NECROSIS; ASTHMA; CATARACT; CHILD; CLINICAL TRIAL; CUSHING DISEASE; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; EMERGENCY MEDICINE; FEMALE; FLUID RETENTION; FLUSHING; FORCED EXPIRATORY VOLUME; GLUCOSE METABOLISM; GROWTH DISORDER; HALLUCINATION; HEART ARRHYTHMIA; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPOTENSION; IMMUNE DEFICIENCY; INTUBATION; KIDNEY FAILURE; LUNG FUNCTION TEST; MALAISE; MALE; MEDICAL DECISION MAKING; MEDICAL NEBULIZER; META ANALYSIS; METERED DOSE INHALER; MOOD DISORDER; MUSCLE WEAKNESS; NEUROTOXICITY; PATHOPHYSIOLOGY; PATIENT MONITORING; PEPTIC ULCER; PHYSICAL EXAMINATION; PREGNANCY; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SIDE EFFECT; TREATMENT INDICATION; WEIGHT GAIN;

EID: 0038012999     PISSN: 07338627     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8627(03)00015-4     Document Type: Review

References (122)

1. Mannino DM, Homa DM, Pertowski CA, et al. Surveillance for asthma - United States, 1960-1995. MMWR Morb Mortal Wkly Rep 1998;47:1-28.
2. CDC. Asthma mortality and hospitalization among children and young adults - United States, 1980-93. MMWR Morb Mortal Wkly Rep 1966;45:50-3.
3. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhino-conjunctivitis, and atopic eczema: ISAAC. Lancet 1998;351:1225-32.
4. CDC. Forecasted state-specific estimates of self-reported asthma prevalence - United States, 1998. MMWR Morb Mortal Wkly Rep 1998;47:1022-5.
5. Pappas G, Hadden WC, Kozak LJ, et al. Potentially avoidable hospitalizations: inequalities in rates between US socioeconomic groups. Am J Public Health 1997;87:811-6.
6. Weiss KB, Gergen PG, Hodgson TA. An economic evaluation of asthma in the United States. N Engl J Med 1992;326:862-6.
7. McFadden ER, Gilbert IA. Asthma. N Engl J Med 1992;327:1928.
8. Cydulka RK, McFadden ER, Emerman CL, et al. Patterns of hospitalization in elderly patients with asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997;156:1807-12.
9. McDowell KM. Pathophysiology of asthma. Respir Care Clin N Am 2000;6:15-26.
10. Fabbri LM, Caramori G, Beghe B, et al. Physiologic consequences of long-term inflammation. Am J Respir Crit Care Med 1998;157:S195-8.
11. Lange P, Parner J, Vestbo J, et al. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998;339:1194-200.
12. Barbee RA, Dodge R, Lebowitz MI, et al. The epidemiology of asthma. Chest 1985; 87(Suppl):21 S-5S.
13. CDC. Surveillance for asthma - United States, 1960-1995. MMWR Morb Mortal Wkly Rep 1998;47(no SS-1):1-28.
14. Weiss KB, Gergen PJ, Wagener DK. Breathing better or wheezing worse? The changing epidemiology of asthma morbidity and mortality. Annu Rev Public Health 1993;14:491-513.
15. Busse WW, Gern JE. Viruses in asthma. J Allergy Clin Immunol 1997;100:147-50.
16. National Heart, Lung, and Blood Institute, National Asthma Education and Prevention Program. Expert Panel Report 2: guidelines for the diagnosis and management of asthma. Pub no 97-4051. Bethesda, MD: National Institutes of Health; 1997.
17. Cydulka RK, Emerman CL, Rowe BH, et al. Differences between men and women in reporting of symptoms during an asthma exacerbation. Ann Emerg Med 2001;38:123-8.
18. Cardin DL, Nowak RM, Sarkar D, et al. Vital signs including pulsus paradoxus in the assessment of acute bronchial asthma. Ann Emerg Med 1983;12:80-3.
19. McFadden ER Jr. Clinical physiologic correlates in asthma. J Allergy Clin Immunol 1986;77(1 Pt 1):1-5.
20. Fischl MA, Pitchenik A, Gardner LB. An index predicting relapse and need for hospitalization in patients with acute asthma. N Engl J Med 1981;305:783-9.
21. Centor RM, Yarborough B, Wood JP. Inability to predict relapse in acute asthma. N Engl J Med 1984;310:577-80.
22. Enright PL, Lebowitz MD, Cockroft DW. Physiologic measures: pulmonary function tests: asthma outcome. Am J Respir Crit Care Med 1994;149:S9-18.
23. McCarthy DS, Craig DB, Cherniack RM. Intraindividual variability in maximum expiratory flow volume and closing volume in asymptomatic subjects. Am Rev Respir Dis 1975;112:407-11.
24. Nickerson BG, Lemon RJ, Gerdes CB, et al. Within-subject variability and percent change for significance of spirometry in normal subjects and in patients with cystic fibrosis. Am Rev Respir Dis 1980;122:859-66.
25. Vaughan TR, Weber RW, Tipton WR, et al. Comparison of PEFR and FEV1 in patients with varying degrees of lung obstruction: effect of modest altitude. Chest 1989;95:558-62.
26. Nowak RM, Pensler MI, Sarkar DD. Comparison of peak expiratory flow and FEV1, admission criteria for acute bronchial asthma. Ann Emerg Med 1982; 11:64.
27. Rodrigo G, Rodrigo C. A new index for early prediction of hospitalization in patients with acute asthma. Am J Emerg Med 1997;15:8-13.
28. Emerman CL, Cydulka RK. Factors associated with relapse following emergency department treatment for acute asthma. Ann Emerg Med 1995;26:6-11.
29. Emerman CL, Woodruff PG, Cydulka RK, et al. Prospective multicenter study of relapse following treatment for acute asthma among adults presenting to the emergency department. MARC investigators. Multicenter Asthma Research Collaboration. Chest 1999;115:919-27.
30. Martin TG, Elenbaas RM, Pingleton SH. Failure of peak expiratory flow rate to predict hospital admission in acute asthma. Ann Emerg Med 1982;11:466-70.
31. Martin TG, Elenbaas RM, Pingleton SH. Use of peak expiratory flow rates to eliminate unnecessary arterial blood gases in acute asthma. Ann Emerg Med 1982;11:70.
32. Greening AP, Wind P, Northfield M, et al. Added salmeterol versus higher dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994;344:219-24.
33. Moore RH, Khan A, Dickey B. Long-acting inhaled beta-2 agonists in asthma therapy. Chest 1998;113:1095-108.
34. Pauwels RA, Lofdahl CG, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med 1997;337:1405-11.
35. Woolcock A, Lundback B, Ringdal N, et al. Comparison of addition of salmeterol to inhaled steroids with doubling the dose of inhaled steroid. Am J Respir Crit Care Med 1996;153:1481-8.
36. Rudnitsky GS, Eberlein RS, Schoffstall JM, et al. Comparison of intermittent and continuously nebulized albuterol for treatment of asthma in an urban emergency department. Ann Emerg Med 1993;22:1842-6.
37. Bowton DL, Goldsmith WM, Haponik EF. Substitution of metered-dose inhalers for hand-held nebulizers: success and cost-savings in a large, acute care hospital. Chest 1992;101:305-8.
38. Chou KJ, Cunningham SJ, Crain EF. Metered-dose inhalers with spacers vs nebulizers for pediatric asthma. Arch Pediatr Adolesc Med 1995;149:201-5.
39. Idris AH, McDermott MF, Raucci JC, et al. Emergency department treatment of severe asthma: metered-dose inhaler plus holding chamber is equivalent in effectiveness to nebulizer. Chest 1993;103:665-72.
40. Kerem E, Levison H, Schuh S, et al. Efficacy of albuterol administered by nebulizer versus spacer device in children with acute asthma. J Pediatr 1993;123:313-7.
41. Leversha AM, Campanella SG, Aickin RP, et al. Costs and effectiveness of spacer versus nebulizer in young children with moderate and severe acute asthma. J Pediatr 2000; 136:497-502.
42. Turner JR, Corkery KJ, Eckman D, et al. Equivalence of continuous flow nebulizer and metered-dose inhaler with reservoir bag for treatment of acute airflow obstruction. Chest 1988;93:476-81.
43. Quadrel M, Lavery RF, Jaker M, et al. Prospective, randomized trial of epinephrine, metaproterenol, and both in the prehospital treatment of asthma in the adult patient. Ann Emerg Med 1995;26:469-73.
44. Oats J, Wood A. Ipratropium bromide. N Engl J Med 1988;319:486-93.
45. Karpel JP, Schacter EN, Fanta C, et al. A comparison of ipratropium and albuterol vs albuterol alone for the treatment of acute asthma. Chest 1996; 110:611-6.
46. O'Driscoll BR, Taylor RJ, Horsley MG, et al. Nebulized salbutamol with and without ipratropium bromide in acute airflow obstruction. Lancet 1989;1:1418-20.
47. FitzGerald JM, Grunfeld A, Pare P, et al. The clinical efficacy of combination nebulized anticholinergic and adrenergic bronchodilators vs nebulized adrenergic bronchodilator alone in acute asthma. Chest 1997;111:311-5.
48. Goggin N, Macarthur C, Parkin PC. Randomized trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalized because of an acute asthma exacerbation. Arch Pediatr Adolesc Med 2001;155:1329-34.
49. Lanes SF, Garrett JE, Wentworth CE, et al. The effect of adding ipratropium bromide to salbutamol in the treatment of acute asthma: a pooled analysis of three trials. Chest 1998;114:365-72.
50. Lin RY, Pesola GR, Bakalchuk L, et al. Superiority of ipratropium plus albuterol over albuterol alone in the emergency department management of adult asthma: a randomized clinical trial. Ann Emerg Med 1998;31:208-13.
51. Qureshi F, Pestian J, Davis P. Effect of nebulized ipratropium on the hospitalization rates of children with asthma. N Engl J Med 1998;339:1030-5.
52. Qureshi F, Zarutsky A, Lakkis H. Efficacy of nebulized ipratropium in severely asthmatic children. Ann Emerg Med 1997;29:205-11.
53. Schuh S, Johnson DW, Callahan S, et al. Efficacy of frequent nebulized ipratropium bromide added to frequent high-dose albuterol therapy in severe childhood asthma. J Pediatr 1995;126:639-45.
54. Stoodley RG, Aaron SD, Dales RE. The role of ipratropium bromide in the emergency management of acute asthma exacerbation: a metaanalysis of randomized clinical trials. Ann Emerg Med 1999;34:8-18.
55. Rodrigo G, Rodrigo C, Burschtin O. A meta-analysis of the effects of ipratropium bromide in adults with acute asthma. Am J Med 1999;107:363-70.
56. Tan KS, Grove A, McLean A, et al. Systemic corticosteroid rapidly reverses bronchodilator subsensitivity induced by formoterol in asthmatic patients. Am J Respir Crit Care Med 1997;156:28-35.
57. Chapman KR, Verbeek PR, White JG, et al. Effect of a short course of prednisone in the prevention of early relapse after the emergency room treatment of acute asthma. N Engl J Med 1991;324:788.
58. Rowe BH, Spooner CH, Ducharme FM, et al. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Review. The Cochrane Library, Issue 1, 2002.
59. Barnett PL, Caputo GL, et al. Intravenous versus oral corticosteroids in the management of acute asthma in children. Ann Emerg Med 1997;29:212-7.
60. Gries DM, Moffitt DR, et al. A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children. J Pediatr 2000;136:298-303.
61. Rowe BH, Spooner CH, Ducharme FM, et al. Corticosteroids for preventing relapse following acute exacerbations of asthma. Cochrane Review. The Cochrane Library, Issue 1, 2002.
62. Rodrigo C, Rodrigo G. Corticosteroids in the emergency department therapy of acute adult asthma: an evidence-based evaluation. Chest 1999;116:285-95.
63. Lin RY, Pesola GR, Bakalchuk L, et al. Rapid improvement of peak flow in asthmatic patients treated with parenteral methylprednisolone in the emergency department: a randomized controlled study. Ann Emerg Med 1999;33:487-94.
64. Blais L, Ernst P, Boivin JF, et al. Inhaled corticosteroids and the prevention of readmission to hospital for asthma. Am J Respir Crit Care Med 1998;158:126-32.
65. Wennergren G, Kristjansson S, Strannegard IL. Decrease in hospitalization for treatment of childhood asthma with increased use of anti-inflammatory treatment, despite an increase in the prevalence of asthma. J Allergy Clin lmmunol 1996;97:742-8.
66. Donahue JG, Weiss ST, Livingston JM, et al. Inhaled steroids and the risk of hospitalization for asthma. JAMA 1997;277:887-91.
67. Suissa S, Baltzan M, Benayoun S, et al. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 2000;343:332-6.
68. Edmonds ML, et al. Early use of inhaled corticosteroids in the emergency department treatment of acute asthma. Cochrane Review. The Cochrane Library, Issue 1, 2002.
69. Afilalo M, Colacone A, Dankoff J, et al. Efficacy of inhaled steroids (beclomethasone dipropionate) for treatment of mild to moderately severe asthma in the emergency department: a randomized clinical trial. Ann Emerg Med 1999;33:304-9.
70. Edmonds ML, et al. Inhaled steroids for acute asthma following emergency department discharge. Cochrane Review. The Cochrane Library, Issue 1, 2002.
71. Rodrigo G, Rodrigo C. Inhaled flunisolide for acute severe asthma. Am J Respir Crit Care Med 1998;157:698-703.
72. Rowe BH, Bota GW, Fabris L, et al. Inhaled budesonide in addition to oral corticosteroids to prevent asthma relapse following discharge from the emergency department. JAMA 1999;281:2119-26.
73. Cydulka RK, Emerman CL. A pilot study of steroid therapy in the prevention of early relapse after emergency department treatment of acute asthma: is a taper needed? J Emerg Med 1998;16:15-9.
74. Parameswaran K, et al. Addition of intravenous aminophylline to beta2-agonists in adults with acute asthma. Cochrane Review. The Cochrane Library, Issue 1, 2002.
75. Bone R, Calverley P, Chapman K, et al. The International Clinical Respiratory Group: special report. Chest 1992;101:1420-4.
76. Coleridge J, Cameron P, Epstein J, et al. Intravenous aminophylline confers no benefit in acute asthma treated with intravenous steroids and inhaled bronchodilators. Aust N Z J Med 1993;23:348-54.
77. Fanta CH, Rossing TH, McFadden ER Jr. Treatment of acute asthma: is combination therapy with sympathomimetics and methylxanthines indicated? Am J Med 1986;80:5-10.
78. Murphy DG, McDermott MF, Rydman RJ, et al. Aminophylline in the treatment of acute asthma when beta 2-adrenergics and steroids are provided. Arch Intern Med 1993;153:1784-8.
79. Rodrigo C, Rodrigo G. Treatment of acute asthma: lack of therapeutic benefit and increased toxicity from aminophylline given in addition to high doses of salbutamol delivered by MDI with a spacer. Chest 1994;106:1071-6.
80. Rossing TH, Fanta CH, Goldstein DH, et al. Emergency therapy of asthma: comparison of the acute effects of parenteral and inhaled sympathomimetics and infused aminophylline. Am Rev Respir Dis 1980;122:365-71.
81. Jenne JW. Two new roles for theophylline in the asthmatic. J Asthma 1995;32:89-95.
82. Evans DJ, Taylor DA, Zetterstrom O, et al. A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma, N Engl J Med 1997;337:1412-8.
83. Rivington R, Boulet LP, Cote J, et al. Efficacy of uniphyl, salbutamol, and their combination in asthmatic patients on high-dose inhaled steroids. Am J Respir Crit Care Med 1995;151:325-32.
84. Altman LC, Munk Z, Seltzer J, et al. A placebo-controlled, dose-ranging study of monteleukast, a cysteinyl leukotriene-receptor antagonist. J Allergy Clin Immunol 1998; 102:50-6.
85. Lipworth BJ. Leukotriene-receptor antagonists. Lancet 1999;353:57-62.
86. Reiss TF, Chervinsky P, Dockhorn RJ, et al. Monteleukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma. Arch Intern Med 1998;158:1213-20.
87. Suissa S, Dennis R, Ernst P, et al. Effectiveness of the leukotriene receptor antagonist zafirlukast for mild-to-moderate asthma. Ann Intern Med 1997;126:177-83.
88. Tamaoki J, Kondo M, Sakai N, et al. Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. Am J Respir Crit Care Med 1997;155:1235-40.
89. Camargo CA, Green SA, Smithline HA, et al. Rapid bronchodilator response to intravenous montelukast in acute asthma [abstract]. Acad Emerg Med 2001;8:414.
90. Marin J, Carrizo S, Garcia R, et al. Effects of nedocromil sodium in steroid-resistant asthma: a randomized controlled trial. J Allergy Clin Immunol 1996;97:602-10.
91. Pawls R. The current place of necrodomil sodium in the treatment of asthma. J Allergy Clin lmmunol 1996;98:S151-6.
92. Scarfone RJ, et al. A randomized trial of magnesium in the emergency department treatment of children with asthma. Ann Emerg Med 2000;36:572-8.
93. Bloch H, Silverman R, Mancherje N, et al. Intravenous magnesium sulfate as an adjunct in the treatment of acute asthma. Chest 1995;107:1576-81.
94. Ciarallo L, Brousseau D, Reinert S. Higher-dose intravenous magnesium therapy for children with moderate to severe acute asthma. Arch Pediatr Adolesc Med 2000;154:979-83.
95. Tiffany BR, Berk WA, Todd IK, et al. Magnesium bolus or infusion fails to improve expiratory flow in acute asthma exacerbations. Chest 1993;104:831-4.
96. Rowe BH, Bretzlaff JA, Bourdon C, et al. Intravenous magnesium sulfate treatment for acute asthma in the emergency department: a systematic review of the literature. Ann Emerg Med 2000;36:181-90.
97. Manthous CA, Hall JB, Melmed A, et al. Heliox improves pulsus paradoxus and peak expiratory flow in non-intubated patients with severe asthma. Am J Respir Crit Care Med 1995;151:310-4.
98. Kass JE, Castriotta RJ. Heliox therapy in acute severe asthma. Chest 1995;107:757-60.
99. Kress JP, et al. The utility of albuterol nebulized with heliox during acute ashtma exacerbations. Am J Respir Crit Care Med 2002;165:1317-21.
100. Henderson SO, Acharya P, et al. Use of heliox-driven nebulizer therapy in the treatment of acute asthma. Ann Emerg Med 1999;33:141-6.
101. L'Hommedieu CSA, Arens JJ. The use of ketamine for the emergency intubation of patients with status asthmaticus. Ann Emerg Med 1987;16:568-71.
102. Sarma V. Ketamine and asthma. Acta Scand 1992;36:1507-10.
103. Jagoda A, Shepherd SM, Spevitz A, et al. Refractory asthma:. Part 1. epidemiology, pathophysiology, pharmacologic interventions. Ann Emerg Med 1997;29:262-74.
104. O'Rourke P, Crone R. Halothane in status asthmaticus. Crit Care Med 1982;10:341-3.
105. Tuxen DV. Permissive hypercapnic ventilation. Am J Respir Crit Care Med 1994; 150:870-4.
106. Leatherman JW. Mechanical ventilation in obstructive lung disease. Clin Chest Med 1996;17:577-90.
107. Pepe PE, Marini JJ. Occult positive end-expiratory pressure in mechanically ventilated patients with airflow obstruction: the auto-PEEP effect. Am Rev Respir Dis 1982;126:166-70.
108. Werner C. Ventilatory management of respiratory failure in asthma. JAMA 1993; 269:2128-31.
109. Cydulka RK, Emerman CL, Schreiber D, et al. Acute asthma among pregnant women presenting to the emergency department. Am J Respir Crit Care Med 1999;160:887-92.
110. Schatz M. Interrelationships between asthma and pregnancy: a literature review. J Allergy Clin Immunol 1999;103:S330-6.
111. Schatz M, et al. Asthma and allergy in pregnancy. Clin Perinatol 1997;24:407-32.
112. Schatz M, Zeiger RS, Harden K, et al. The safety of asthma and allergy medications during pregnancy. J Allergy Clin lmmunol 1997;100:301-6.
113. Schatz M, Zeiger RS, Harden KM, et al. The safety of inhaled beta-agonist bronchodilators during pregnancy. J Allergy Clin Immunol 1988;82:686-95.
114. Stenius-Aarnial BSM, Hedman J, Teramo KA. Acute asthma during pregnancy. Thorax 1996;51:411-4.
115. Barnes PJ, Pedersen S. Efficacy and safety of inhaled steroids in asthma. Am Rev Respir Dis 1993;148:S1-26.
116. Kamada AK, Szefler SJ, Martin RJ, et al. and the Asthma Clinical Research Network. Issues in the use of inhaled glucocorticoids. Am J Respir Crit Care Med 1996;153:1739-48.
117. Ninan TK, Russel G. Asthma, inhaled corticosteroid treatment and growth. Arch Dis Chil 1992;67:703-5.
118. Spock A. Growth patterns in 200 children with bronchial asthma. Ann Allergy 1965;23:608-15.
119. Wolthers OD. Long-, intermediate- and short-term growth studies in asthmatic children treated with inhaled glucosteroids. Eur Respir J 1996;9:821-7.
120. Skobeloff EM, Spivey WH, St. Clair SS, et al. The influence of age and sex on asthma admissions. JAMA 1992;268:3437-40.
121. Brillman JC, Tandberg D. Observation unit impact on ED admission for asthma. Am J Emerg Med 1994;12:11-4.
122. Rydman RJ, Isola ML, Roberts RR, et al. Emergency department observation unit versus hospital inpatient care for a chronic asthmatic population: a randomized trial of health status outcome and cost. Med Care 1998;36:599-609.